114 related articles for article (PubMed ID: 11673334)
1. Living the dream of no restenosis.
Teirstein PS
Circulation; 2001 Oct; 104(17):1996-8. PubMed ID: 11673334
[No Abstract] [Full Text] [Related]
2. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
Sousa JE; Costa MA; Abizaid AC; Rensing BJ; Abizaid AS; Tanajura LF; Kozuma K; Van Langenhove G; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
Circulation; 2001 Oct; 104(17):2007-11. PubMed ID: 11673337
[TBL] [Abstract][Full Text] [Related]
3. The CARI guidelines. Pharmacological approaches to preventing vascular access failure.
Polkinghorne K;
Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S12-6. PubMed ID: 18713119
[No Abstract] [Full Text] [Related]
4. Clinical experience of sirolimus-eluting stents in patients with coronary artery disease at Bangkok Heart Institute.
Lolekha P; Bhuripanyo K; Kukreja R; Mahanonda N; Numee M
J Med Assoc Thai; 2003 May; 86 Suppl 1():S76-82. PubMed ID: 12866772
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents, restenosis and revascularization.
Ramcharitar S; Gaster AL; Daemen J; Serruys P
Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
[TBL] [Abstract][Full Text] [Related]
6. [The Nordic Bifurcation Study. Randomized study on the question of optimal stenting technique for bifurcating stenosis].
Herz; 2006 May; 31(3):257. PubMed ID: 17431944
[No Abstract] [Full Text] [Related]
7. Effectiveness of drug-eluting stents in patients with bare-metal in-stent restenosis: meta-analysis of randomized trials.
Dibra A; Kastrati A; Alfonso F; Seyfarth M; Pérez-Vizcayno MJ; Mehilli J; Schömig A
J Am Coll Cardiol; 2007 Feb; 49(5):616-23. PubMed ID: 17276188
[TBL] [Abstract][Full Text] [Related]
8. Late stent thrombosis: problem or not?
Somberg J; Weinberger J
Am J Cardiol; 2007 Apr; 99(7):1020-3. PubMed ID: 17398205
[No Abstract] [Full Text] [Related]
9. [Position paper on the use of drug eluting stents in coronary heart disease].
Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
[No Abstract] [Full Text] [Related]
10. [Drug-eluting coronary stents and drug eluting balloon catheters: summary of the position papers of the DGK].
Silber S; Borggrefe M; Böhm M; Hoffmeister HM; Dietz R; Ertl G; Heusch G
Clin Res Cardiol; 2008 Aug; 97(8):548-63. PubMed ID: 18726643
[No Abstract] [Full Text] [Related]
11. Programmable elution profile coating for drug eluting stents.
Al-Lamee K
Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
[TBL] [Abstract][Full Text] [Related]
12. Vascular pathology of drug-eluting stents.
Nakazawa G; Finn AV; Virmani R
Herz; 2007 Jun; 32(4):274-80. PubMed ID: 17607533
[TBL] [Abstract][Full Text] [Related]
13. Stent placement to prevent restenosis after angioplasty in small coronary arteries.
Doucet S; Schalij MJ; Vrolix MC; Hilton D; Chenu P; de Bruyne B; Udayachalerm W; Seth A; Bilodeau L; Reiber JH; Harel F; Lespérance J;
Circulation; 2001 Oct; 104(17):2029-33. PubMed ID: 11673341
[TBL] [Abstract][Full Text] [Related]
14. Sirolimus-eluting stent implantation in ST-elevation acute myocardial infarction: a clinical and angiographic study.
Saia F; Lemos PA; Lee CH; Arampatzis CA; Hoye A; Degertekin M; Tanabe K; Sianos G; Smits PC; McFadden E; Hofma SH; van der Giessen WJ; de Feyter PJ; van Domburg RT; Serruys PW
Circulation; 2003 Oct; 108(16):1927-9. PubMed ID: 14557354
[TBL] [Abstract][Full Text] [Related]
15. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis.
Nordmann AJ; Briel M; Bucher HC
Eur Heart J; 2006 Dec; 27(23):2784-814. PubMed ID: 17020889
[TBL] [Abstract][Full Text] [Related]
16. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
17. A novel bioengineered small-caliber vascular graft incorporating heparin and sirolimus: excellent 6-month patency.
Ishii Y; Sakamoto S; Kronengold RT; Virmani R; Rivera EA; Goldman SM; Prechtel EJ; Hill JG; Damiano RJ
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1237-45; discussion 1245-6. PubMed ID: 18544361
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stent update 2007: part III: Technique and unapproved/unsettled indications (left main, bifurcations, chronic total occlusions, small vessels and long lesions, saphenous vein grafts, acute myocardial infarctions, and multivessel disease).
Colombo A; Chieffo A
Circulation; 2007 Sep; 116(12):1424-32. PubMed ID: 17875983
[No Abstract] [Full Text] [Related]
19. SCAI statement on drug-eluting stents: practice and health care delivery implications.
Hodgson JM; King SB; Feldman T; Cowley MJ; Klein LW; Babb JD;
Catheter Cardiovasc Interv; 2003 Mar; 58(3):397-9. PubMed ID: 12594710
[No Abstract] [Full Text] [Related]
20. Use of SafeCut Balloon for treatment of in-stent restenosis of a previously underexpanded sirolimus-eluting stent with a heavily calcified plaque.
Otsuka Y; Kasahara Y; Kawamura A
J Invasive Cardiol; 2007 Dec; 19(12):E359-62. PubMed ID: 18180527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
